XENIA HOTELS & RESORTS INC (XHR)

US9840171030 - REIT

14.13  -0.01 (-0.07%)

After market: 14.13 0 (0%)

Fundamental Rating

3

Taking everything into account, XHR scores 3 out of 10 in our fundamental rating. XHR was compared to 126 industry peers in the Diversified REITs industry. While XHR seems to be doing ok healthwise, there are quite some concerns on its profitability. XHR is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
XHR had a positive operating cash flow in the past year.
In multiple years XHR reported negative net income over the last 5 years.
Of the past 5 years XHR 4 years had a positive operating cash flow.

1.2 Ratios

XHR has a Return On Assets of 0.65%. This is comparable to the rest of the industry: XHR outperforms 52.03% of its industry peers.
XHR has a Return On Equity (1.46%) which is comparable to the rest of the industry.
XHR has a Return On Invested Capital (2.78%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.65%
ROE 1.46%
ROIC 2.78%
ROA(3y)-0.73%
ROA(5y)-1.16%
ROE(3y)-1.57%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of XHR (1.84%) is comparable to the rest of the industry.
XHR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.49%, XHR is doing worse than 81.30% of the companies in the same industry.
In the last couple of years the Operating Margin of XHR has declined.
XHR has a Gross Margin of 55.31%. This is in the lower half of the industry: XHR underperforms 77.24% of its industry peers.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 9.49%
PM (TTM) 1.84%
GM 55.31%
OM growth 3YN/A
OM growth 5Y-4.65%
PM growth 3YN/A
PM growth 5Y-36.78%
GM growth 3Y13.94%
GM growth 5Y-1.03%

4

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
XHR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, XHR has less shares outstanding
Compared to 1 year ago, XHR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that XHR is in the distress zone and has some risk of bankruptcy.
XHR's Altman-Z score of 0.72 is fine compared to the rest of the industry. XHR outperforms 62.60% of its industry peers.
The Debt to FCF ratio of XHR is 18.08, which is on the high side as it means it would take XHR, 18.08 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 18.08, XHR is doing good in the industry, outperforming 73.17% of the companies in the same industry.
A Debt/Equity ratio of 1.08 is on the high side and indicates that XHR has dependencies on debt financing.
XHR has a Debt to Equity ratio (1.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 18.08
Altman-Z 0.72
ROIC/WACC0.36
WACC7.8%

2.3 Liquidity

XHR has a Current Ratio of 1.49. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.49, XHR is doing good in the industry, outperforming 60.16% of the companies in the same industry.
A Quick Ratio of 1.49 indicates that XHR should not have too much problems paying its short term obligations.
XHR's Quick ratio of 1.49 is fine compared to the rest of the industry. XHR outperforms 64.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49

4

3. Growth

3.1 Past

The earnings per share for XHR have decreased strongly by -65.31% in the last year.
The earnings per share for XHR have been decreasing by -33.93% on average. This is quite bad
Looking at the last year, XHR shows a small growth in Revenue. The Revenue has grown by 2.79% in the last year.
The Revenue has been decreasing by -0.63% on average over the past years.
EPS 1Y (TTM)-65.31%
EPS 3YN/A
EPS 5Y-33.93%
EPS growth Q2Q-77.42%
Revenue 1Y (TTM)2.79%
Revenue growth 3Y40.49%
Revenue growth 5Y-0.63%
Revenue growth Q2Q-3.69%

3.2 Future

XHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.58% yearly.
Based on estimates for the next years, XHR will show a small growth in Revenue. The Revenue will grow by 2.97% on average per year.
EPS Next Y72.29%
EPS Next 2Y43.58%
EPS Next 3Y22.58%
EPS Next 5YN/A
Revenue Next Year3.38%
Revenue Next 2Y3.98%
Revenue Next 3Y2.97%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 83.12, XHR can be considered very expensive at the moment.
XHR's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 24.92, XHR is valued quite expensively.
XHR is valuated quite expensively with a Price/Forward Earnings ratio of 48.24.
XHR's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.49. XHR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 83.12
Fwd PE 48.24

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 76.42% of the companies listed in the same industry.
XHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. XHR is cheaper than 71.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.67
EV/EBITDA 11.64

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
XHR's earnings are expected to grow with 22.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.15
PEG (5Y)N/A
EPS Next 2Y43.58%
EPS Next 3Y22.58%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.97%, XHR has a reasonable but not impressive dividend return.
XHR's Dividend Yield is slightly below the industry average, which is at 6.06.
XHR's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.97%

5.2 History

The dividend of XHR decreases each year by -17.85%.
XHR has been paying a dividend for over 5 years, so it has already some track record.
The dividend of XHR decreased recently.
Dividend Growth(5Y)-17.85%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

XHR pays out 236.80% of its income as dividend. This is not a sustainable payout ratio.
DP236.8%
EPS Next 2Y43.58%
EPS Next 3Y22.58%

XENIA HOTELS & RESORTS INC

NYSE:XHR (4/26/2024, 7:25:08 PM)

After market: 14.13 0 (0%)

14.13

-0.01 (-0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.44B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.97%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 83.12
Fwd PE 48.24
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.65%
ROE 1.46%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.49%
PM (TTM) 1.84%
GM 55.31%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-65.31%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y72.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.79%
Revenue growth 3Y40.49%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y